bluebird bio (BLUE) Earnings Date, Estimates & Call Transcripts $8.41 -0.56 (-6.24%) (As of 05:44 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends bluebird bio Latest Earnings SummaryLatest Q2 2024 Earnings DateSep. 27EstimatedActual EPS (Sep. 27) -$8.40 Missed By -$0.40 Consensus EPS (Sep. 27) -$8.00 bluebird bio issued Q2 2024 earnings on September 27, 2024, reporting an EPS of -$8.40, which missed the consensus estimate of -$8.00 by $0.40. Quarterly revenue was reported to be $16.10 million, above analyst estimates of $16.09 million. With a trailing EPS of -$37.40, bluebird bio's earnings are expected to grow next year, from ($1.35) to ($0.41) per share. Get bluebird bio Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on bluebird bio and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBLUE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BLUE Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. bluebird bio Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20244-$0.69-$0.29-$0.53Q2 20244-$0.69-$0.33-$0.51Q3 20244-$0.58-$0.39-$0.47Q4 20244-$0.50-$0.22-$0.40FY 202416-$2.46-$1.23-$1.90Q1 20254-$0.38-$0.07-$0.24Q2 20254-$0.33-$0.05-$0.17Q3 20254-$0.36$0.01-$0.15Q4 20254-$0.51-$0.04-$0.23FY 202516($1.58)($0.15)($0.79) bluebird bio Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails9/27/2024Q2 2024-$8.00-$8.40 -$0.40-$0.42$16.09M$16.10M9/13/2024Q1 2024--$7.20 -$7.20-$0.36-$18.57M11/7/2023Q3 2023-$13.80-$13.20+$0.60-$0.66$13.56M$12.40M8/8/2023Q2 2023-$14.40-$13.40+$1.00-$0.67$11.30M$6.90M5/9/2023Q1 2023-$10.80$4.20+$15.00$0.21$26.97M$2.40M3/29/2023Q4 2022-$9.00$7.60+$16.60$0.38$102.24M$0.06M Get the Latest News and Ratings for BLUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for bluebird bio and its competitors with MarketBeat's FREE daily newsletter. bluebird bio Earnings - Frequently Asked Questions When did bluebird bio announce their last quarterly earnings? bluebird bio (NASDAQ:BLUE) last announced its quarterly earning data on Friday, September 27, 2024. Learn more on BLUE's earnings history. What guidance has bluebird bio issued on next quarter's earnings? bluebird bio updated its fourth quarter 2024 earnings guidance on Thursday, November, 14th. The company issued revenue guidance of $25.0 million-, compared to the consensus revenue estimate of $29.4 million. Did bluebird bio beat their earnings estimates last quarter? In the previous quarter, bluebird bio (NASDAQ:BLUE) missed the analysts' consensus estimate of ($8.00) by $0.40 with a reported earnings per share (EPS) of ($8.40). Learn more on analysts' earnings estimate vs. BLUE's actual earnings. How much revenue does bluebird bio generate each year? bluebird bio (NASDAQ:BLUE) has a recorded annual revenue of $53.12 million. How much profit does bluebird bio generate each year? bluebird bio (NASDAQ:BLUE) has a recorded net income of -$211.91 million. BLUE has generated -$37.40 earnings per share over the last four quarters. What is bluebird bio's EPS forecast for next year? bluebird bio's earnings are expected to grow from ($1.35) per share to ($0.41) per share in the next year. More Earnings Resources from MarketBeat Related Companies Krystal Biotech Earnings Arcellx Earnings ADMA Biologics Earnings Immunovant Earnings Scholar Rock Earnings CRISPR Therapeutics Earnings Denali Therapeutics Earnings Twist Bioscience Earnings Vericel Earnings SpringWorks Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings 2025’s #1 Trump Trade (Ad)All the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies Set to See Enormous Profit Potential.Details Here. This page (NASDAQ:BLUE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bluebird bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bluebird bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
